You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動 | 開拓藥業(9939.HK)大漲13.45% 旗下藥物可抑制新冠患者轉重症
格隆匯 01-11 13:09
格隆匯1月11日丨開拓藥業(9939.HK)高開高走,現漲幅擴大至13.45%,報11.98港元,總市值44億港元。開拓藥業昨日公佈旗下普克魯胺用於治療新冠病毒患者的臨牀數據。用於治療新冠男性受試者的臨牀試驗最終數據顯示,可顯著抑制新冠男性受試者自輕症至重症的轉化,且短期用藥(口服15天)安全性良好。普克魯胺可顯著降低新冠男性受試者的住院率,且在研究期間未觀察到與普克魯胺相關的不良事件。在巴西進行的普克魯胺治療新冠女性受試者的中期數據與治療新冠男性受試者的臨牀試驗結果一致,均可顯著降低新冠患者自輕症至重症的轉化。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account